BRCA2 c.1325_1326delinsTT ;(p.S442F)

Variant ID: 13-32906940-CA-TT

NM_000059.3(BRCA2):c.1325_1326delinsTT;(p.S442F)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy.

Bmc Cancer
Zaidieh, Tarek T; Smith, James R JR; Ball, Karen E KE; An, Qian Q
Publication Date: 2021-04-17

Variant appearance in text: BRCA2: S442F
PubMed Link: 33865346
Variant Present in the following documents:
  • 12885_2021_Article_8155.pdf
View BVdb publication page